Administrative Core
行政核心
基本信息
- 批准号:7728797
- 负责人:
- 金额:$ 24.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-01 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:BiometryCancer VaccinesClinicClinical ResearchClinical TrialsDataDiscipline of NursingGrantImmunologyMaintenanceMemorial Sloan-Kettering Cancer CenterNursesNursing ResearchPatient MonitoringPatientsPharmacistsPharmacy facilityPlayProtocols documentationRecordsRegulatory AffairsResearchRoleStructureToxic effectUnited States Food and Drug AdministrationVaccinesdata managementdesignexperiencefollow-upnovelpre-clinicalprogramsquality assuranceresearch study
项目摘要
The Administrative Core includes biostatistics, clinical trials management, nursing, and pharmacy. This core
plays an integral part in all projects, providing a closely interactive biostatistics group that is integrated into
each Project, nursing, data management and pharmacy support for all clinical trials throughout Projects 1-3.
The role of the biostatistics group for this project is to contribute to the design, conduct and analysis of the
clinical trials, and preclinical experiments. The Administrative Core supports data management through the
Office of Clinical Research at MSKCC. This office is responsible for patient registration, data management
support, quality assurance/control, regulatory affairs and interfacing with the FDA, protocol oversight, and
assisting protocol review. The data managers on this program attend meetings weekly and participate in
clinic sessions where patients are treated. The Immunology Research Nurses are experienced nurses who
deliver therapies including mAb and vaccines, perform patient monitoring, and record data of toxicity. Finally
the research pharmacist handles and stores vaccines, and prepares them for treatment, with maintenance of
appropriate records.
行政核心包括生物统计学,临床试验管理,护理和药学。这一核心
在所有项目中起着不可或缺的作用,提供了一个紧密互动的生物统计组,
每个项目,护理,数据管理和药房支持整个项目1-3的所有临床试验。
本项目生物统计组的作用是为设计、实施和分析
临床试验和临床前实验。管理核心通过
MSKCC临床研究办公室。这个办公室负责病人登记,数据管理
支持、质量保证/控制、法规事务和与FDA的接口、方案监督,以及
协助方案审查。此计划中的数据管理员每周参加会议,
病人接受治疗的诊所。免疫学研究护士是经验丰富的护士,
提供包括mAb和疫苗在内的治疗,进行患者监测,并记录毒性数据。最后
研究药剂师处理和储存疫苗,并为治疗做好准备,
适当的记录。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALAN N. HOUGHTON其他文献
ALAN N. HOUGHTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALAN N. HOUGHTON', 18)}}的其他基金
相似海外基金
Enhancing Ribonucleic Acid (RNA) Cancer Vaccines by Combining Circular RNA and Costimulatory Adjuvants
通过结合环状 RNA 和共刺激佐剂增强核糖核酸 (RNA) 癌症疫苗
- 批准号:
486081 - 财政年份:2022
- 资助金额:
$ 24.07万 - 项目类别:
Studentship Programs
Investigating Immune Responses to Neoantigen Cancer Vaccines using In Vivo Functionalized Lineage
使用体内功能化谱系研究对新抗原癌症疫苗的免疫反应
- 批准号:
10558688 - 财政年份:2022
- 资助金额:
$ 24.07万 - 项目类别:
Nanoscale Metal-Organic Frameworks as X-ray Activatable Cancer Vaccines
纳米级金属有机框架作为 X 射线激活癌症疫苗
- 批准号:
10558960 - 财政年份:2022
- 资助金额:
$ 24.07万 - 项目类别:
AltRNA8V antigens for Cancer Vaccines
用于癌症疫苗的 AltRNA8V 抗原
- 批准号:
10025636 - 财政年份:2022
- 资助金额:
$ 24.07万 - 项目类别:
Collaborative R&D
Development of Rationally Designed Cancer Vaccines Using Protein-like Polymers (PLPs)
使用类蛋白聚合物 (PLP) 开发合理设计的癌症疫苗
- 批准号:
10152127 - 财政年份:2021
- 资助金额:
$ 24.07万 - 项目类别:
An integrated polymeric carrier for subunit cancer vaccines
用于亚单位癌症疫苗的集成聚合物载体
- 批准号:
10366085 - 财政年份:2021
- 资助金额:
$ 24.07万 - 项目类别:
Synthesis of oligosaccharides and glycoconjugates to develop anti-cancer vaccines
合成寡糖和糖复合物以开发抗癌疫苗
- 批准号:
RGPIN-2016-03820 - 财政年份:2021
- 资助金额:
$ 24.07万 - 项目类别:
Discovery Grants Program - Individual
Reprogramming the tumour microenvironment using a platform of virally encoded exosome-based cancer vaccines
使用病毒编码的基于外泌体的癌症疫苗平台重新编程肿瘤微环境
- 批准号:
454485 - 财政年份:2021
- 资助金额:
$ 24.07万 - 项目类别:
Fellowship Programs
Investigating TLR-agonist adjuvancy in STING-activating nanoparticle cancer vaccines
研究 STING 激活纳米颗粒癌症疫苗中的 TLR 激动剂佐剂
- 批准号:
10558717 - 财政年份:2021
- 资助金额:
$ 24.07万 - 项目类别:
An Engineered Nanocarrier Platform for Enhancing Immune Responses to Neoantigen-Targeted Cancer Vaccines
用于增强新抗原靶向癌症疫苗免疫反应的工程纳米载体平台
- 批准号:
10560602 - 财政年份:2021
- 资助金额:
$ 24.07万 - 项目类别:














{{item.name}}会员




